Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visibility of Site Marking with Chloraprep vs Duraprep
NCT00739583Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2008
- Primary completion
- Aug 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorhexidine + alcohol, iodine povacrylex in surgical site infection (SSI), sponsored by Johns Hopkins University. Started Aug 2008; status: completed.
02
Drugs
chlorhexidine + alcoholiodine povacrylex
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT00739583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00739583.